Julianne Bruno

Julianne Bruno has filed trades across 2 companies (mainly through SEC (Form 4)), most often in CRISPR Therapeutics AG and Damora Therapeutics, Inc. The record holds 5 filings, for trades running from 20 June 2024 to 9 February 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 12 February 2026, reports an option exercise in Damora Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.